The News

The News

Portfolio Companies in the News

» 10/01/12
Omthera Pharmaceuticals announces Positive Long Term Bioavailability data comparing Epanova™ to Lovaza®

» 13/12/11
Ablynx initiates Phase I study with ALX-0171 for the treatment of respiratory syncytial virus (RSV)

» 06/12/11
DBV Technologies proudly welcomes Mr. David Schilansky as its new Chief Financial Officer

» 30/11/11
Ablynx reports positive Phase I data for ALX-0061 in rheumatoid arthritis

» 29/11/11
NuCana BioMed Secures $10.4 Million Series A Financing to accelerate its ProTide Anti-Cancer Drugs into Clinical Development

» 22/11/11
UCB acquires Lectus Therapeutics’ key pharmaceutical assets Agreement adds novel ion channel drug discovery and development programmes for CNS indications to UCB’s New Medicines™ research technologies portfolio

» 14/11/11
BioAmber Strengthens its Management Team and Board of Directors

» 17/10/11
Hookipa Biotech Closes €7 million Series A Financing Led by Sofinnova Partners

» 13/09/11
OpenERP among 20 Hot International Startups You Need To Watch

» 14/09/11
BioAmber Partners with PTTMCC Biochem for PBS production in Thailand

» 13/09/01
Ascendis Pharma reports positive Phase 2 results for its once-weekly human growth hormone product, ACP-001, in growth hormone deficient adults.

» 08/09/11
Tapform allows developers, publishers and hardware manufacturers to harness the power of the Taptu news-aggregating engine

» 08/09/11
Qosmos Closes €19.8 Million Funding Round with DFJ Esprit, FSI and Alven Capital

» 05/08/11
Jeff Kolstad joins Avantium as Chief Scientist to accelerate bioplastics development

» 04/08/11
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer

Click here for the site of Sofinnova Ventures, our sister firm in San Francisco http://www.sofinnova.com